Observational studyInternational journal of molecular sciences2023

90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients.

Pasqua Letizia Pesole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.